2023 annual financial data
Acrivon Therapeutics 2023 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -67,237,000 USD and net income was -60,388,000 USD.
Operating cash flow was -42,641,000 USD.
Get free Acrivon Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -67,237,000 USD
- Net income
- -60,388,000 USD
- Operating cash flow
- -42,641,000 USD